Chemotherapy induced agranulocytopenia is treated with-

The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy. Chemotherapy-induced neutropenia increases a patient's risk of infection and disrupts cancer treatment. the use of recombinant human G-CSF (filgrastim) to treat cancer patients undergoing myelotoxic chemotherapy. Multiple factors affect the severity of neutropenia, most impoant being the type and severity of chemotherapy dosage and the underlying disease Ref Harrison20th edition pg 1179